drugset
drugset / Trial / NCT04108845

Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in Healthy Volunteers Aged Above 2 Months

NCT04108845 ↗

Phase 1 Unknown 80 enrolled Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd Hebei Provincial Center for Diseases Control and Prevention · collabLaishui Center for Disease Control and Prevention · collabNational Institutes for Food and Drug Control, China · collabSimoon Record Pharma Information Consulting Co., Ltd. · collab
NaSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to evaluate safety of 15-Valent Pneumococcal Conjugate Vaccine in healthy volunteers aged above 3 Months.

Timeline

Start
2019-06-05
Primary completion
2020-08
Completion
2020-08

Drugs

EvaluationDrugModalityDoseRoute
Subject 15-Valent Pneumococcal Conjugate Vaccine Vaccine 0.5 ml Intramuscular

Indications

streptococcal pneumonia